Clinical Trial

Using MRI To Detect Soft Tissue Reactions And Implant Integration As Related To Implant Modularity

Recruiting
View on ClinicalTrials.gov →
Summary
Patients with a total hip replacement may require early revision surgery due to an adverse local tissue reaction or bone resorption that occurs due to wear debris released from the implant. MRI provides a non-invasive biomarker for clinicians and surgeons to detect early adverse synovial reactions which may exist in the absence of clinical symptoms, thus imparting essential information for clinical management. This study will address two of the most commons causes of hip implant failure, including adverse local tissue reaction in implants not traditionally associated with adverse tissue reactions, as well as the presence of aseptic loosening and loss of implant-bone integration.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-05 -> 2027-05 2026-07-30
minor Completion pushed: 2026-08 -> 2028-05 2026-07-30
Trial Details
NCT Number NCT02255331
Lead Sponsor Hospital for Special Surgery, New York
Collaborators: Medical College of Wisconsin
Conditions Complications; Arthroplasty, Complications; Arthroplasty, Mechanical
Enrollment 240 participants
Start Date 2017-09-15
Primary Completion 2027-05 (estimated)
Study Completion 2028-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-29